4.6 Article

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013

Journal

MATURITAS
Volume 75, Issue 4, Pages 392-396

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.maturitas.2013.05.013

Keywords

Osteoporosis; Fracture; FRAX; Guideline

Funding

  1. Servier
  2. Consilient Health
  3. Amgen/GSK
  4. Shire
  5. Eli Lilly
  6. Amgen
  7. GSK
  8. MSD
  9. Novartis
  10. Proctor Gamble
  11. ProStrakan
  12. Roche
  13. Medtronic
  14. Tethys
  15. GE Lunar
  16. Bayer
  17. Hologic
  18. Lilly
  19. Merck
  20. Pfizer
  21. Warner-Chilcott
  22. Innovus 3i
  23. Alliance for Better Bone Health
  24. Biointetica
  25. Celtrix
  26. D3A
  27. General Electric
  28. Kissel
  29. Medimaps
  30. Merck Research Labs
  31. Sanofi-Aventis
  32. UBS
  33. Olympus
  34. Synthes
  35. Stryker
  36. Biomet
  37. Medical Research Council [MR/K006312/1] Funding Source: researchfish
  38. MRC [MR/K006312/1] Funding Source: UKRI

Ask authors/readers for more resources

Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available